MilaniB, SholtenW: The World Medicines Situation: Access to Controlled Medicines, 3rd ed. Geneva, Switzerland: World Health Organization; 2011.
3.
The Ethical Canary: Science, Society and the Human Spirit. McGill-Queen's University Press, Quebec, Canada, 2000.
4.
SteinhauserKE, ChristakisNA, ClippEC, et al.: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA, 2000; 284:2476–2482.
5.
TemelJS, GreerJA, MuzikanskyA, et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 2010; 363:733–742.
6.
CurrowDC, ZafarY, FoleyK, et al.: The need for a re-evaluation of best supportive care studies reported to date. Br J Cancer, 2011; 104:390–391.
7.
RheeJY, GarraldaE, NamisangoE, et al.: Developing macroindicators of palliative care development in Africa: A process with in-country and international experts. J Palliat Med, 2018; 21:342–353.
8.
LowD, MerkelEC, MenonM, et al.: End-of-life palliative care practices and referrals in Uganda. J Palliat Med, 2018; 21:328–334.
9.
AbernethyAP, CurrowDC, FazekasBS, et al.: Palliative care services make a difference to short- and long-term caregiver outcomes. J Support Care Cancer, 2008; 16:585–597.